The aim of this study was to investigate the effect of cilostazol on expression of hepatic ABCA1 in a human hepatocellular carcinoma cell line(HepG2) and high-fat-induced dyslipidemic mice. The study was also designed to evaluate whether cilostazol have an effect on hepatic steatosis by increased ABCA1 through HDL-cholesterol level, to maybe a possible mechanism for ameliorating hepatic steatosis.
in vitro study
Subject Oil-Red-O staining was performed (A) and optical density was measured by spectrophotometer (B).
Increased expression of ATP-binding cassette transporter A1 (ABCA1) by cilostazol may be a possible mechanism for its protective effect against hepatic steatosis

